-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PsM5NlTNCFiZ7Iy2umqdgu3Uwp4spNJsmxuULS/u00xL+tJRnhShfeSbe6tVENTU ijFhR/9UQguShqbYHtOlkg== 0000899140-04-000542.txt : 20040421 0000899140-04-000542.hdr.sgml : 20040421 20040421133142 ACCESSION NUMBER: 0000899140-04-000542 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040419 FILED AS OF DATE: 20040421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARBURG PINCUS & CO CENTRAL INDEX KEY: 0000929408 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 04744940 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 100173147 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE STREET 2: NEW YORK CITY: NY STATE: NY ZIP: 100173147 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARBURG PINCUS PRIVATE EQUITY VIII L P CENTRAL INDEX KEY: 0001157334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 04744941 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARBURG PINCUS LLC CENTRAL INDEX KEY: 0001162870 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 04744942 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 3 1 wppe8_neurogen3-042104ex.xml X0201 3 2004-04-19 0 0000849043 NEUROGEN CORP NRGN 0001157334 WARBURG PINCUS PRIVATE EQUITY VIII L P 466 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0000929408 WARBURG PINCUS & CO 466 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0001162870 WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 Common Stock, par value $.025 per share 8571429 D See Exhibit 99. WARBURG PINCUS PRIVATE EQUITY VIII, L.P. /s/ Scott A. Arenare, Partner 2004-04-21 EX-99 4 w2525220.txt EXPLANATION OF RESPONSES Warburg Pincus Private Equity VIII, L.P. 466 Lexington Avenue New York, NY 10017 Neurogen Corporation, NRGN April 19, 2004 EXHIBIT 99 ---------- Explanation of Responses ------------------------ On April 19, 2004, Warburg Pincus Private Equity VIII, L.P. ("WPVIII"), a Delaware limited partnership, purchased 8,571,429 shares of common stock, par value $.025 per share (the "Common Stock"), of Neurogen Corporation (the "Company"), at an aggregate purchase price of $60,000,003, pursuant to a Securities Purchase Agreement, dated as of March 19, 2004 (the "Purchase Agreement"), as amended, by and between the Company, WPVIII and the other investors listed on the signature pages thereto. The sole general partner of WPVIII is Warburg Pincus & Co., a New York general partnership ("WP"). Warburg Pincus LLC, a New York limited liability company ("WP LLC"), manages WPVIII. The members of WP LLC are substantially the same as the partners of WP. By reason of the provisions of Rule 16a-1 of the Securities Exchange Act of 1934, WP and WP LLC may be deemed to be the beneficial owners of Common Stock held by WPVIII, although both WP and WP LLC disclaim beneficial ownership of such securities except to the extent of any indirect pecuniary interest therein. Warburg Pincus Private Equity VIII, L.P. 466 Lexington Avenue New York, NY 10017 Neurogen Corporation, NRGN April 19, 2004 1. Name: Warburg Pincus & Co. (General Partner) Address: 466 Lexington Avenue New York, New York 10017 2. Name: Warburg Pincus LLC (Manager of WP VIII) Address: 466 Lexington Avenue New York, New York 10017 Designated Filer: Warburg Pincus Private Equity VIII, L.P. Issuer & Ticker Symbol: Neurogen Corporation (NRGN) Date of Event Requiring Statement: April 19, 2004 Warburg Pincus Private Equity VIII, L.P. 466 Lexington Avenue New York, NY 10017 Neurogen Corporation, NRGN April 19, 2004 WARBURG PINCUS & CO. By: /s/ Scott A. Arenare April 21, 2004 ------------------------- -------------- Name: Scott A. Arenare Date Title: Partner WARBURG PINCUS LLC By: /s/ Scott A. Arenare April 21, 2004 ------------------------- -------------- Name: Scott A. Arenare Date Title: Member -----END PRIVACY-ENHANCED MESSAGE-----